Detalhe da pesquisa
1.
SARS-CoV-2 Variants and Vaccines.
N Engl J Med
; 385(2): 179-186, 2021 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161052
2.
Nasopharyngeal Carriage of Pneumococcus in Children in England up to 10 Years After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Persistence of Serotypes 3 and 19A and Emergence of 7C.
J Infect Dis
; 227(5): 610-621, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130327
3.
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
Lancet
; 399(10342): 2212-2225, 2022 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35691324
4.
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
Lancet
; 399(10319): 36-49, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34883053
5.
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.
N Engl J Med
; 383(5): 426-439, 2020 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32726529
6.
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.
Clin Exp Immunol
; 211(3): 280-287, 2023 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729167
7.
Clinical and Viral Factors Associated With Disease Severity and Subsequent Wheezing in Infants With Respiratory Syncytial Virus Infection.
J Infect Dis
; 226(Suppl 1): S45-S54, 2022 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35902389
8.
Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18-50 Years and RSV-Seropositive Children 12-24 Months.
J Infect Dis
; 227(1): 71-82, 2022 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36259542
9.
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
Lancet
; 398(10318): 2277-2287, 2021 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774197
10.
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Lancet
; 398(10304): 981-990, 2021 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480858
11.
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
Lancet
; 398(10303): 856-869, 2021 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34370971
12.
Antibody-Dependent Natural Killer Cell Activation After Ebola Vaccination.
J Infect Dis
; 223(7): 1171-1182, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31821493
13.
Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine.
Mol Syst Biol
; 16(11): e9888, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33210468
14.
Persistent Circulation of Vaccine Serotypes and Serotype Replacement After 5 Years of Infant Immunization With 13-Valent Pneumococcal Conjugate Vaccine in the United Kingdom.
J Infect Dis
; 221(8): 1361-1370, 2020 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31004136
15.
Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in Europe.
J Infect Dis
; 222(Suppl 7): S606-S612, 2020 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32794574
16.
Low Sensitivity of BinaxNOW RSV in Infants.
J Infect Dis
; 222(Suppl 7): S640-S647, 2020 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32227106
17.
First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults.
Clin Infect Dis
; 70(10): 2073-2081, 2020 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340042
18.
Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials-GPPAD-02 study design and first results.
Pediatr Diabetes
; 20(6): 720-727, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31192505
19.
Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized study.
BMC Pediatr
; 19(1): 50, 2019 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30732648
20.
Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.
Lancet
; 399(10321): 234-236, 2022 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34942101